Will propranolol become the mainstay of treatment for symptomatic infantile hemangiomas (IH)? Background: IH are the most common tumor of infancy, affecting four to 10 percent of infants. Spontaneous involution […]
Will propranolol become the mainstay of treatment for symptomatic infantile hemangiomas (IH)? Background: IH are the most common tumor of infancy, affecting four to 10 percent of infants. Spontaneous involution […]